Preclinical Pharmacology of AZD5363, an Inhibitor of AKT: Pharmacodynamics, Antitumor Activity, and Correlation of Monotherapy Activity with Genetic BackgroundBarry R. Davies, Martin Pass|Molecular Cancer Therapeutics|2012Cited by 460